A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)
Clinical trial NCT06196879 · COMPLETED
Trial details
- NCT number
- NCT06196879
- Sponsor
- Upstream Bio Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-27
- Primary completion
- 2025-12-16
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.